Page 43 - Read Online
P. 43

Page 8 of 12                           Herrera et al. J Cancer Metastasis Treat 2018;4:42  I  http://dx.doi.org/10.20517/2394-4722.2018.35

               This synergism also accelerates the acquisition of heterogeneity whereby increases in genomic heterogeneity
               will promote heterogeneity of mitochondria function, and vice versa.



               DECLARATIONS
               Acknowledgments
               The authors would like to thank Dr. Sid Das and the Das lab for continuous support and helpful discussions.


               Authors’ contributions
               All authors contributed to the writing of this review. In addition Herrera EL prepared the figures.


               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               Work in our laboratory is partially funded by UTEP’s Research Incentive Program and a grant to LADM
               from BD-Biosciences. Herrera EL is an NIGS RISE-scholar funded by grant R25GM069621-11. Azzam SZ is
               an NSF S-STEM scholar funded by grant DUE1565063.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2018.



               REFERENCES
               1.   Boveri T. Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J Cell Sci
                   2008;121 Suppl 1:1-84.
               2.   Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol 1927;8:519-30.
               3.   Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
               4.   Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
               5.   Reddy EP, Reynolds RK, Santos E, Barbacid M. A point mutation is responsible for the acquisition of transforming properties by the
                   T24 human bladder carcinoma oncogene. Nature 1982;300:149-52.
               6.   Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-
                   Fraumeni syndrome. Nature 1990;348:747-9.
               7.   Stephens PJ, Greenman CD, Fu B,  Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, McLaren S, Lin
                   ML, McBride DJ, Varela I, Nik-Zainal S, Leroy C, Jia M, Menzies A, Butler AP, Teague JW, Quail MA, Burton J, Swerdlow H, Carter
                   NP, Morsberger LA, Iacobuzio-Donahue C, Follows GA, Green AR, Flanagan AM, Stratton MR, Futreal PA, Campbell PJ. Massive
                   genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011;144:27-40.
               8.   Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y, Nezi L, Protopopov A, Chowdhury D, Pellman D. DNA breaks
                   and chromosome pulverization from errors in mitosis. Nature 2012;482:53-8.
               9.   Salk JJ, Fox EJ, Loeb LA. Mutational heterogeneity in human cancers: origin and consequences. Annu Rev Pathol Mech Dis 2010;5:51-75.
               10.  Campbell PJ, Stephens PJ, Pleasance ED, O’Meara S, Li H, Santarius T, Stebbings LA, Leroy C, Edkins S, Hardy C, Teague JW,
                   Menzies A, Goodhead I, Turner DJ, Clee CM, Quail MA, Cox A, Brown C, Durbin R, Hurles ME, Edwards PA, Bignell GR, Stratton
                   MR, Futreal PA. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end
                   sequencing. Nat Genet 2008;40:722-9.
               11.  Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT, Stebbings LA, Leroy C, Edkins S, Mudie LJ, Greenman CD,
   38   39   40   41   42   43   44   45   46   47   48